Two Sigma Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Two Sigma Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$721K	Buy	27,285 +12,775	+88%	+$374K	0.08%	314
2025 Q4	$420K	Buy	+14,510	New	+$436K	0.06%	467
2024 Q1	–	Sell	-10,448	Closed	-$343K	–	2952
2023 Q4	$343K	Sell	10,448 -4,489	-30%	-$122K	﹤0.01%	1875
2023 Q3	$416K	Buy	+14,937	New	+$488K	﹤0.01%	1673
2022 Q1	–	Sell	-6,424	Closed	-$393K	–	2095
2021 Q4	$393K	Buy	+6,424	New	+$444K	0.02%	663

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Two Sigma Securities's ARKG Position: Q1 2026 in Review

Two Sigma Securities increased its ARK Genomic Revolution ETF (ARKG) stake by 88% in Q1 2026, buying an estimated $374K and bringing the position to 27,285 shares worth $721K. The position accounts for 0.08% of the portfolio, ranked #314.

Two Sigma Securities first reported a position in ARKG in Q4 2021 and has held it in 5 quarters since. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

Two Sigma Securities held 27,285 shares of ARK Genomic Revolution ETF worth $721K as of Q1 2026.
Two Sigma Securities bought 12,775 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $374K.
ARK Genomic Revolution ETF made up 0.08% of Two Sigma Securities's portfolio in Q1 2026, its #314 holding.
Two Sigma Securities first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 5 quarters since.
218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.